Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes

NCT00136916 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

635

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Diabetes Mellitus

Interventions

DRUG: Inhaled Insulin
DRUG: Subcutaneous insulin

Sponsor

Pfizer